Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP282867.RAtCEoX6_Mp2xz-Ea9Ox7hf3m60WbFCuFEkIzbQ-qHeLA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP282867.RAtCEoX6_Mp2xz-Ea9Ox7hf3m60WbFCuFEkIzbQ-qHeLA130_assertion type Assertion NP282867.RAtCEoX6_Mp2xz-Ea9Ox7hf3m60WbFCuFEkIzbQ-qHeLA130_head.
- NP282867.RAtCEoX6_Mp2xz-Ea9Ox7hf3m60WbFCuFEkIzbQ-qHeLA130_assertion description "[The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP282867.RAtCEoX6_Mp2xz-Ea9Ox7hf3m60WbFCuFEkIzbQ-qHeLA130_provenance.
- NP282867.RAtCEoX6_Mp2xz-Ea9Ox7hf3m60WbFCuFEkIzbQ-qHeLA130_assertion evidence source_evidence_literature NP282867.RAtCEoX6_Mp2xz-Ea9Ox7hf3m60WbFCuFEkIzbQ-qHeLA130_provenance.
- NP282867.RAtCEoX6_Mp2xz-Ea9Ox7hf3m60WbFCuFEkIzbQ-qHeLA130_assertion SIO_000772 20512928 NP282867.RAtCEoX6_Mp2xz-Ea9Ox7hf3m60WbFCuFEkIzbQ-qHeLA130_provenance.
- NP282867.RAtCEoX6_Mp2xz-Ea9Ox7hf3m60WbFCuFEkIzbQ-qHeLA130_assertion wasDerivedFrom befree-20140225 NP282867.RAtCEoX6_Mp2xz-Ea9Ox7hf3m60WbFCuFEkIzbQ-qHeLA130_provenance.
- NP282867.RAtCEoX6_Mp2xz-Ea9Ox7hf3m60WbFCuFEkIzbQ-qHeLA130_assertion wasGeneratedBy ECO_0000203 NP282867.RAtCEoX6_Mp2xz-Ea9Ox7hf3m60WbFCuFEkIzbQ-qHeLA130_provenance.